Publications by authors named "Vivek Radhakrishnan"

Claim this Profile
E
Evaluation of wound regeneration potential of nano-phytoextracts loaded carboxymethyl chitosan scaffolds for diabetic foot ulcer.
Vivek Radhakrishnan, Leah Sabu, Prathik Somayaji, Monika Prakash, Shwetha Krishnamurthy

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients.
Vivek S Radhakrishnan, Peter W M Johnson

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic potential of silkworm sericin in wound healing applications.
Monika Prakash, Chandraprabha Mathikere Naganna, Vivek Radhakrishnan, Prathik Somayaji, Leah Sabu

Wound Repair Regen· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the treatment and management of adult B-Cell acute lymphoblastic leukemia in Asia-Pacific: Outcomes from a pilot initiative.
Zhentang Lao, Kwong Yok Lam, Yuk Man Carol Cheung, Chieh-Lin Teng, Vivek Radhakrishnan

Asia Pac J Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthy tissue metabolism assessed by [F]FDG PET/CT as a marker of prognosis and adverse events in advanced Hodgkin lymphoma patients.
Afnan A Malaih, Amy A Kirkwood, Peter Johnson, Vivek Radhakrishnan, Barbara M Fischer

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor T-cell based cellular therapies for cancer: An introduction and Indian perspective.
Reena J Rathod, Reghu K Sukumaran, Neelam Kedia, Jeevan Kumar, Reena Nair, Vivek Sulekha Radhakrishnan

Indian J Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody based therapies in Hodgkin lymphoma.
Vivek S Radhakrishnan, Jemma Longley, Peter W M Johnson

Cancer Treat Rev· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific antibodies in indolent B-cell lymphomas.
Vivek S Radhakrishnan, Andrew J Davies

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on the management of chronic lymphocytic leukaemia in Asia.
Eric Tse, Yok Lam Kwong, Yeow Tee Goh, Ping Chong Bee, Soo Chin Ng, Vivek Radhakrishnan

Clin Exp Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-based induction therapy followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients: A single-center experience and review of Indian literature.
Manthan Kathrotiya, Vivek Radhakrishnan, Saurabh J Bhave, Arijit Nag, Neeraj Arora

Indian J Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in India: An Indian expert consensus.
Jagdish Chander Mohan, Jamshed Dalal, Vijay Kumar Chopra, Calambur Narasimhan, Prafulla Kerkar, Vivek Radhakrishnan

Indian Heart J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should we adopt an automated de-centralized model of chimeric antigen receptor- T cells manufacturing for low-and middle-income countries? A real world perspective.
Sharanya Ramakrishnan, Jeevan Kumar, Suvro Sankha Datta, Vivek Radhakrishnan, Reena Nair

Front Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral T-Cell Lymphoma, Hemophagocytic Lymphohistiocytosis, and XIAP Gene Mutations: Getting the Treatment Right!
Vinay Anand Guntiboina, Vivek S Radhakrishnan, Jeevan Kumar, Saurabh J Bhave, Sushant Vinarkar

Clin Lymphoma Myeloma Leuk· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mantle cell lymphoma: A clinical review of the changing treatment paradigms with the advent of novel therapies, and an insight into Indian data.
Vivek Sulekha Radhakrishnan, Padmaja Lokireddy, Mayur Parihar, Prashanth Srirangapattana Prakash, Hari Menon

Cancer Rep (Hoboken)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Study to Determine the Utility of Automated Tissue Dissociator for Flowcytometry Based Evaluation of Hematolymphoid Tumor Tissue Biopsies.
Tanusri Karmakar, Sambhunath Banerjee, Subhajit Brahma, Debdeep Dey, Vivek Radhakrishnan

Indian J Hematol Blood Transfus· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from India.
George Abraham, Vanita Noronha, Senthil Rajappa, Amit Agarwal, Ullas Batra, Vivek Radhakrishnan

Int J Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precursor B-cell acute lymphoblastic leukaemia-a global view.
Andrea Biondi, Valentino Conter, Mammen Chandy, Primus Ewald, Marie Lucia de Martino Lee, Vivek S Radhakrishnan

Br J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed Refractory Hodgkin Lymphoma and Brentuximab Vedotin-Bendamustine Combination Therapy as a Bridge to Transplantation: Real-World Evidence From a Middle-Income Setting and Literature Review.
Vivek S Radhakrishnan, Rajat Bajaj, Vasundhara Raina, Jeevan Kumar, Saurabh J Bhave

Front Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on peripheral stem cell collection and preservation at a hematopoietic cell transplant center in India: Experience 2020.
Rizwan Javed, Mita Roychowdhury, Saurabh Bhave, Arijit Nag, Jeevan Kumar, Vivek Radhakrishnan

Blood Cell Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Cytogenetic Strategy to Identify Masked Hypodiploidy in Precursor B Acute Lymphoblastic Leukemia in Low Resource Settings.
Tanvi Gupta, S R Arun, G Ashish Babu, Barun Kumar Chakrabarty, Saurabh Jayant Bhave, Vivek Radhakrishnan

Indian J Hematol Blood Transfus· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Quality and Efficacy of Apheresis Platelets Stored in Platelet Additive Solution Vis a Vis Plasma.
Debapriya Basu, Sabita Basu, Vivek S Radhakrishnan, Sanjay Bhattacharya, Subhosmito Chakraborty

Indian J Hematol Blood Transfus· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab biosimilars for B-cell lymphomas: a decade of real-world experience from India.
Reena Nair, Vivek S Radhakrishnan, Mohandas K Mallath

Lancet Haematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting.
Chandrayee Sarker, Vivek S Radhakrishnan, Payal Mandal, Jeevan Kumar, Saurabh Bhave

Ecancermedicalscience· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapsed plasmablastic lymphoma in a HIV-negative patient: Pushing the envelope.
Manthan Kathrotiya, Vivek S Radhakrishnan, Saurabh J Bhave, Jeevan Kumar, Mita Roychowdhury

Clin Case Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meeting Proceedings of the 2nd Annual Immuno-Oncology Society of India Conference (I-OSICON-2020), Mumbai, India.
Jyoti Bajpai, Sujay Srinivas, George Abraham, Shubhada V Chiplunkar, Hemant Malhotra, Vivek Radhakrishnan

J Immunother Precis Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis